Navigation Links
Report confirms increased risk of smoking, substance abuse in bipolar adolescents
Date:6/2/2008

th diagnosed BPD, who enrolled at an average age of 14, the study includes 98 control participants of the same age, carefully screened to rule out mood disorders.

Incidence of each measure alcohol abuse or dependence, drug abuse or dependence, and smoking was significantly higher in participants with BPD than in the control group. Overall, rates of substance use/abuse were 34 percent in the bipolar group and 4 percent in controls. When adjusted to account for co-occurring behavioral and psychiatric conditions, the results still indicated significantly higher risk in the bipolar group. Analyzing how the onset of bipolar symptoms related to when substance abuse began, revealed that BPD came first in most study participants.

The data also indicated that bipolar youth whose symptoms began in adolescence were more likely to abuse drugs and alcohol than were those whose symptoms began in childhood. "It could be that the onset of mood dysregulation in adolescence puts kids at even higher risk for poor judgement and self-medication of their symptoms," Wilens says. "It also could be that some genetic switch activated in adolescence turns on both BPD and substance abuse in these youngsters. That's something that we are currently investigating in genetic and neuroimaging studies of this group."

He adds that clarifying whether bipolar disorder begins before substance abuse starts could have "a huge impact. If BPD usually precedes substance abuse, there may be intervention points where we could reduce its influence on drug and alcohol abuse. Aggressive treatment of BPD could cut the risk of substance abuse, just as we have shown it does in ADHD." Wilens is an associate professor of Psychiatry at Harvard Medical School.


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO
2. New data show patients using avonex reported less sick leave and short-term disability costs
3. Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex
4. Chem Rx Corporation Reports First Quarter 2008 Financial Results
5. Multiple Independent Studies Report on Use of Cylexs Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients
6. U.S.News & World Report Debuts First Specialty Rankings of Americas Best Childrens Hospitals
7. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
8. The Childrens Hospital of Philadelphia Ranks Number One in U.S. News & World Reports 2008 Edition of Americas Best Childrens Hospitals
9. CRH Medical reports Q1 2008 results
10. Cardiovascular Meds May Be Beneficial in Alzheimers Disease, According to MedPredict Report
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ... that Schneider Electric has completed its upgrade and expansion of its ... with more than 170,000 employees in 134 countries supplying a wide range of ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... of Directors has authorized the Company, from time to time and depending on ... value of up to $25 million. Repurchases will be made in open market ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women fear developing Alzheimer's disease ... that cancer, heart attack, and stroke are treatable, but there is little an individual ... is to take part in a clinical trial, reports the July 2015 Harvard ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published by ... Study Says " sheds light on a possible new treatment option for people living ... of regular HBOT sessions, at least five per week, patients experienced a significant decrease ...
(Date:7/28/2015)... ... ... Most employers have been using multi-tier prescription drug plans for many years, but ... in the use of 4-tier plans, which typically cover the highest cost drugs, as ... to continue, according to UBA. , UBA’s survey finds that, since 2009, the number ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5
... LOS ANGELES, May 29 Writers and producers,from ... others were honored,at the 2008 Voice Awards last ... Administration (SAMHSA), hosted by award-winning actor and,mental health ... at Paramount Studios in Los Angeles., Winners ...
... ALOKA announced today new compact,ProSound ultrasound Systems which ... Federation of Societies for Ultrasound in Medicine and ... in Timisoara, Romania. The ProSound 2 is a,portable ... functions. High image quality technologies developed for,the premium ...
... The gene that allows fireflies to flash is helping ... UT Southwestern Medical Center researchers are among the first to ... used to determine the effectiveness of cancer drugs that choke ... requires a substrate called luciferin to be added to the ...
... More northern women feel bloating and,gurgling than their southern ... it at any one time, according to a TNS ... and Yorkshire and Humberside fared the,worst (71%), with Greater ... bloated feelings. And 61% of British women experience feeling,bloated, ...
... receiving the necessary symptom management that they require to ... its treatment, or both, according to a leading professor ... million people around the world (10 million in the ... newly diagnosed with cancer can expect to live at ...
... July 10 Cash Dividend ... - Preliminary Proxy Results, WALNUT CREEK, Calif., May 28 ... and the,preliminary proxy results at its 2008 Annual Meeting of Stockholders., ... dividend on common shares of $0.14 per share payable July,10, 2008 to ...
Cached Medicine News:Health News:SAMHSA Honors 'The Sopranos,' 'Monk,' 'Dirt' at Star-Studded Voice Awards in Los Angeles 2Health News:SAMHSA Honors 'The Sopranos,' 'Monk,' 'Dirt' at Star-Studded Voice Awards in Los Angeles 3Health News:SAMHSA Honors 'The Sopranos,' 'Monk,' 'Dirt' at Star-Studded Voice Awards in Los Angeles 4Health News:ALOKA to Unveil a New Compact 'ProSound' Diagnostic Ultrasound System 2Health News:Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness 2Health News:Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness 3Health News:North South Divide Exists in UK Digestive Health 2Health News:North South Divide Exists in UK Digestive Health 3Health News:Cancer survivors are living 'in limbo' with unmet needs for care 2Health News:Cancer survivors are living 'in limbo' with unmet needs for care 3Health News:Longs Drug Stores Corporation Announced at Its Annual Meeting of Stockholders 2
(Date:7/28/2015)... FORT WORTH, Texas , July 28, 2015 /PRNewswire/ ... Report "Global Dermatology Devices Market by Type (Dermatology Treatment ... MRI, CT), Dermatoscopes, Microscopes]), by Application, by Geography - ... market is expected to reach $11.88 billion by 2019, ... Browse through the TOC of Global Dermatology ...
(Date:7/28/2015)... , July 28, 2015 Research ... addition of the "Global Hearing Aids Market ... The global hearing aids market to grow ... 2014-2019. Factors such as changing ... driving market growth. The market has witnessed immense ...
(Date:7/28/2015)... 2015   CSL Behring announced today ... Authorization Application (MAA) for the company,s investigational long-acting ... recombinant albumin (rIX-FP) for the prophylaxis and treatment ... Upon Swissmedic approval, rIX-FP will provide hemophilia B ... intervals up to 14 days. ...
Breaking Medicine Technology:Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4
... Phosphagenics,Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today ... undertake a Phase 1 transdermal,oxycodone clinical trial aimed ... management product. Phosphagenics has submitted all necessary ... be conducted at CMAX - an independent clinical ...
... Phase 2 clinical development, PRINCETON, N.J., Sept. ... in the discovery and development of novel,small molecule ... 2a,clinical study of PS433540, the company,s lead internal ... receptor antagonist,(DARA) that is being developed as a ...
Cached Medicine Technology:Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 4Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 5
... Intelli-Storeroom™ was developed to create physically secured ... and exits are converted to RFID portals. ... readers and antennas by VerdaSee's Field Engineering ... to assets that are to be tracked. ...
... Mobile Aspects provides hospitals ... products to track all their ... Our RFID systems remove all ... items and people accurately. iRIS, ...
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
... AgileTrac Surgical Services is a Web-based ... to track, manage, and measure patient flow ... process, from admission to discharge. AgileTrac collects ... of care delays your patient might experience. ...
Medicine Products: